Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Recruitment for the position of Assistant Professor in the Laboratory of Genomics and bioinformatics
Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences | Poland | about 1 month agofor scientific positions at the Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences. Competition documentation is available at: https://hirszfeld.pl/instytut/oferty-pracy/zasady
-
/or epigenomic profiling and annotation, methods to study genome structure, genome and nucleic acid imaging, cell reprogramming, precision medicine, and gene and cell therapies including new delivery
-
The Jiang Lab, The Icahn School of Medicine at Mount Sinai | New York City, New York | United States | about 2 months ago
tools into next-generation gene therapies to treat those untreatable human genetic diseases, such as cystic fibrosis. To achieve this, we will engineer advanced CRISPR tools to correct or model
-
strong background in CAR-T cell biology, as well as clinical research and an understanding of regulatory requirements related to cell and gene therapy (CGT). This position will work directly with the Gates
-
production processes for cell and gene therapy products into a robust cGMP manufacturing process. The specialist will produce cell therapy drug products in a GMP environment to ensure timely, cost-effective
-
coordination of gene and cellular therapy trials to be conducted by University of Nebraska Medical Center (UNMC) and/or Nebraska Medicine (NM) investigators. This individual will be responsible for the initial
-
tolerance and treat disease at reduced doses, understanding the mechanisms driving immune tolerance following AAV liver-directed gene therapy, and evaluating the immune responses associated with AAV
-
in vivo gene therapy, with >200 clinical trials and six products approved in Europe. However, rAAV manufacturing remains inefficient, and manufacturing thus proposes a significant bottleneck for safe
-
Mycobacterium tuberculosis), macrophage biology, host-directed therapies, antimicrobial drug development, wastewater surveillance, and cancer therapeutics. The successful candidate is expected to lead a project
-
of treatment are a significant factor inhibiting the use of High Flow Nasal Cannula Therapy among some clinicians. Using data from clinical collaborators around the world, this project will develop a user